According to a recent study published in the journal Oncogene, a new strategy for treating glioblastoma (GBM) may be blocking an enzyme called PRMT5 in tumor cells. PRMT5, which is shorthand for protein arginine methyltransferase 5, regulates gene transcription and other cell processes.
A new study published in JAMA Internal Medicine reveals that exercise significantly reduces the risk of developing 13 different varieties of cancer. Cancer Institute researchers gathered data from over 1.44 million men and women.
An experimental therapy is showing the ability to stop aggressive, treatment-resistant and deadly brain cancers in laboratory tests and mouse models.
A team led by researchers at Cincinnati Children’s Hospital Medical Center published their results on May 9, 2016.
Jane Ishamel, Ph.D., associate professor of pharmacology at Oregon State University, found that a new compound produced by an ancient species of algae, coibamide A, may have potent anti-cancer activities.
Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) in La Jolla, California have identified a new combination therapy for the most aggressive form of medulloblastoma, a fast-growing brain cancer occurring mostly in pediatric tumors.